Transient expression technologies: Past, present, and future

Methods in Molecular Biology

Volumn 899, Issue , 2012, Pages 203-219

  Geisse, Sabine ^a   Voedisch, Bernd ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

CHO cells; HEK293 cells; Lipofection; Polyethylenimine; Recombinant protein expression; Transient transfection

Indexed keywords

LIPOPEPTIDE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN HEK293; CHEMISTRY; CHO CELL; CULTURE MEDIUM; CYTOLOGY; GENE EXPRESSION; GENE VECTOR; GENETIC PROCEDURES; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY;

ANIMALS; CHO CELLS; CRICETINAE; CULTURE MEDIA; GENE EXPRESSION; GENETIC TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; LIPOPEPTIDES; RECOMBINANT PROTEINS; TRANSFECTION;

MAMMALIA;

EID: 84864123068     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-921-1_13     Document Type: Article

References (94)

1. Pham PL, Kamen A, Durocher Y (2006) Largescale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol 34:225-237
2. Baldi L, Hacker DL, Adam M, Wurm FM (2007) Recombinant protein production by large-scale transient gene expression in mammalian cells: State of the art and future perspectives. Biotechnol Lett 29:677-684
3. Durocher Y, Butler M (2009) Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol 20:700-707
4. Geisse S (2009) Reflections on more than 10 years of TGE approaches. Protein Expr Purif 64:99-107
5. Raymond C, Tom R, Perret S, Moussouami P, L'Abbe D, St-Laurent G, Durocher Y (2011) A simplified polyethylenimine-mediated transfection process for large-scale and high-throughput applications. Methods 55(1):44-51
6. Geisse S, Jordan M, Wurm F (2005) Largescale transient expression of therapeutic proteins in mammalian cells. In: Smales C, James D (eds) Therapeutic proteins. Humana Press, Totowa NJ, pp 87-98
7. Geisse S, Fux C (2009) Recombinant protein production by transient gene transfer into mammalian cells. Methods Enzymol 463:223-238
8. Graham FL, Smiley J, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-72
9. Kishida T, Asada H, Kubo K, Sato YT, Shin-Ya M, Imanishi J, Yoshikawa K, Mazda O (2008) Pleiotrophic functions of Epstein-Barr virus nuclear antigen-1 (EBNA-1) and oriP differentially contribute to the ef fi cacy of transfection/ expression of exogenous gene in mammalian cells. J Biotechnol 133:201-207
10. Norseen J, Thomae A, Sridharan V, Aiyar A, Schepers A, Lieberman PM (2008) RNAdependent recruitment of the origin recognition complex. EMBO J 27:3024-3035
11. Prasad TK, Rao NM (2005) The role of plasmid constructs containing the SV40 DNA nuclear-targeting sequence in cationic lipidmediated DNA delivery. Cell Mol Biol Lett 10:203-215
12. Wang S, Frappier L (2009) Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation. J Virol 83:11704-11714
13. Cho MS, Yee H, Chan S (2002) Establishment of a human somatic hybrid cell line for recombinant protein production. J Biomed Sci 9:631-638
14. Cho M-S, Yee H, Brown C, Jeang K-T, Cahn S (2001) An oriP expression vector containing the HIV Tat/TAR transactivation axis produces high levels of protein expression in mammalian cells. Cytotechnology 37:23-30
15. Liu C, Dalby B, Chen W, Kilzer JM, Chiou HC (2008) Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells. Mol Biotechnol 39:141-153
16. Laengle-Rouault F, Patzel V, Benavente A, Taillez M, Silvestre N, Bompard A, Sczakiel G, Jacobs E, Rittner K (1998) Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: Implications of the nuclear import of plasmids. J Virol 72:6181-6185
17. Mairhofer J, Grabherr R (2008) Rational vector design for Efficient non-viral gene delivery: Challenges facing the use of plasmid DNA. Mol Biotechnol 39:97-104
18. Durocher Y, Perret S, Kamen A (2002) Highlevel and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 30:E9
19. Parham J, Kost T, Hutchins J (2001) Effects of pCIneo and pCEP4 expression vectors on transient and stable protein production in human and simian cell lines. Cytotechnology 35:181-187
20. Berntzen G, Lunde E, Flobakk M, Andersen JT, Lauvrak V, Sandlie I (2005) Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells. J Immunol Methods 298:93-104
21. Durocher Y, Loignon M (2011) US Patent Application Publication US2011/0039339 A1
22. Silla T, Haal I, Geimanen J, Janikson K, Abroi A, Ustav E, Ustav M (2005) Episomal maintenance of plasmids with hybrid origins in mouse cells. J Virol 79:15277-15288
23. Codamo J, Munro TP, Hughes BS, Song M, Gray PP (2011) Enhanced CHO cell-based transient gene expression with the Epi-CHO expression system. Mol Biotechnol 48:109-115
24. Backliwal G, Hildinger M, Kuettel I, Delegrange F, Hacker DL, Wurm FM (2008) Valproic acid: A viable alternative to sodium butyrate for enhancing protein expression in mammalian cell cultures. Biotechnol Bioeng 101:182-189
25. Rajendra Y, Kiseljak D, Baldi L, Hacker DL, Wurm FM (2011) A simple high-yielding process for transient gene expression in CHO cells. J Biotechnol 153:22-26
26. Backliwal G, Hildinger M, Chenuet S, de Jesus M, Wurm FM (2008) Coexpression of acidic fi broblast growth factor enhances specific productivity and antibody titers in transiently transfected HEK293 cells. N Biotechnol 25: 162-166
27. Zhang X, Stettler M, De Sanctis D, Perrone M, Parolini N, Discacciati M, De Jesus M, Hacker D, Quarteroni A, Wurm F (2010) Use of orbital shaken disposable bioreactors for mammalian cell cultures from the milliliter-scale to the 1,000-liter scale. Adv Biochem Eng Biotechnol 115:33-53
28. Pichler J, Galosy S, Mott J, Borth N (2011) Selection of CHO host cell subclones with increased specific antibody production rates by repeated cycles of transient transfection and cell sorting. Biotechnol Bioeng 108:386-394
29. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc Natl Acad Sci USA 92:7297-7301
30. Derouazi M, Girard P, Fv T, Iglesias K, Muller N, Bertschinger M, Wurm FM (2004) Serumfree large-scale transient transfection of CHO cells. Biotechnol Bioeng 87:537-545
31. Galbraith DJ, Tait AS, Racher AJ, Birch JR, James DC (2006) Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells. Biotechnol Prog 22:753-762
32. Huh SH, Do HJ, Lim HY, Kim DK, Choi SJ, Song H, Kim NH, Park JK, Chang WK, Chung HM, Kim JH (2007) Optimization of 25 kDa linear polyethylenimine for Efficient gene delivery. Biologicals 35:165-171
33. Sun X, Hia HC, Goh PE, Yap MG (2008) High-density transient gene expression in suspension- adapted 293 EBNA1 cells. Biotechnol Bioeng 99:108-116
34. Chenuet S, Martinet D, Besuchet-Schmutz N, Wicht M, Jaccard N, Bon AC, Derouazi M, Hacker DL, Beckmann JS, Wurm FM (2008) Calcium phosphate transfection generates mammalian recombinant cell lines with higher specific productivity than polyfection. Biotechnol Bioeng 101:937-945
35. Kichler A, Leborgne C, Danos O (2005) Dilution of reporter gene with stuffer DNA does not alter the transfection ef fi ciency of polyethylenimines. J Gene Med 7:1459-1467
36. Backliwal G, Hildinger M, Hasija V, Wurm FM (2008) High-density transfection with HEK- 293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI. Biotechnol Bioeng 99:721-727
37. Fliedl L, Kaisermayer C (2011) Transient gene expression in HEK293 and vero cells immobilised on microcarriers. J Biotechnol 153:15-21
38. Bertschinger M, Backliwal G, Schertenleib A, Jordan M, Hacker DL, Wurm FM (2006) Disassembly of polyethylenimine-DNA particles in vitro: Implications for polyethyleniminemediated DNA delivery. J Control Release 116:96-104
39. Bertschinger M, Schertenleib A, Cevey J, Hacker D, Wurm F (2008) The kinetics of polyethylenimine-mediated transfection in suspension culture of Chinese hamster ovary cells. Mol Biotechnol 40:136-143
40. Ye J, Kober V, Tellers M, Naji Z, Salmon P, Markusen JF (2009) High-level protein expression in scalable CHO transient transfection. Biotechnol Bioeng 103:542-551
41. Eberhardy SR, Radzniak L, Liu Z (2009) Iron (III) citrate inhibits polyethylenimine-mediated transient transfection of Chinese hamster ovary cells in serum-free medium. Cytotechnology 60:1-9
42. Tuvesson O, Uhe C, Rozkov A, Lullau E (2008) Development of a generic transient transfection process at 100 L scale. Cytotechnology 56:123-136
43. Muller N, Girard P, Hacker DL, Jordan M, Wurm FM (2005) Orbital shaker technology for the cultivation of mammalian cells in suspension. Biotechnol Bioeng 89:400-406
44. Bollin F, Dechavanne V, Chevalet L (2011) Design of experiment in CHO and HEK transient transfection condition optimization. Protein Expr Purif 78:61-68
45. Haldankar R, Danqing L, Saremi Z, Baikalov C, Deshpande R (2006) Serum-free suspension large-scale transient transfection of CHO cells in wave bioreactors. Mol Biotechnol 34:191-199
46. Dang JM, Leong KW (2006) Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev 58:487-499
47. Jiang HL, Kim TH, Kim YK, Park IY, Cho MH, Cho CS (2008) Efficient gene delivery using chitosan-polyethylenimine hybrid systems. Biomed Mater 3:25013
48. Kusumoto K, Akao T, Mizuki E, Nakamura O (2006) Gene transfer effects on various cationic amphiphiles in CHO cells. Cytotechnology 51:57-66
49. Stettler M, Zhang X, Hacker DL, Md J, Wurm FM (2007) Novel orbital shake bioreactors for transient production of CHO derived IgGs. Biotechnol Prog 23:1340-1346
50. Chapple SD, Crofts AM, Shadbolt SP, McCafferty J, Dyson MR (2006) Multiplexed expression and screening for recombinant protein production in mammalian cells. BMC Biotechnol 6:49
51. Zhao Y, Bishop B, Clay JE, Lu W, Jones M, Daenke S, Siebold C, Stuart DI, Yvonne Jones E, Radu Aricescu A (2011) Automation of large scale transient protein expression in mammalian cells. J Struct Biol 175(2):209-215
52. Xia W, Bringmann P, McClary J, Jones PP, Manzana W, Zhu Y, Wang S, Liu Y, Harvey S, Madlansacay MR, McLean K, Rosser MP, MacRobbie J, Olsen CL, Cobb RR (2006) High levels of protein expression using different mammalian CMV promoters in several cell lines. Protein Expr Purif 45:115-124
53. Mariati Ng YK, Chao SH, Yap MG, Yang Y (2010) Evaluating regulatory elements of human cytomegalovirus major immediate early gene for enhancing transgene expression levels in CHO K1 and HEK293 cells. J Biotechnol 147:160-163
54. Mariati Ho SC, Yap MG, Yang Y (2010) Evaluating post-transcriptional regulatory elements for enhancing transient gene expression levels in CHO K1 and HEK293 cells. Protein Expr Purif 69:9-15
55. Klein R, Ruttkowski B, Knapp E, Salmons B, Gunzburg WH, Hohenadl C (2006) WPREmediated enhancement of gene expression is promoter and cell line specific. Gene 372: 153-161
56. Kim K-S, Kim M, Moon J, Jeong M, Kim J, Lee G, Myung P-K, Hong H (2009) Enhancement of recombinant antibody production in HEK293E cells by WPRE. Biotechnol Bioproc Eng 14:633-638
57. Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM (2008) Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res 36:e96
58. Kwaks TH, Otte AP (2006) Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends Biotechnol 24:137-142
59. Harraghy N, Regamey A, Girod PA, Mermod N (2011) Identi fi cation of a potent MAR element from the mouse genome and assessment of its activity in stable and transient transfections. J Biotechnol 154:11-20
60. Chateauvieux S, Morceau F, Dicato M, Diederich M (2010) Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol 2010:479364
61. Wulhfard S, Baldi L, Hacker DL, Wurm F (2010) Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells. J Biotechnol 148:128-132
62. Jiang Z, Sharfstein ST (2008) Sodium butyrate stimulates monoclonal antibody over-Expression in CHO cells by improving gene accessibility. Biotechnol Bioeng 100:189-194
63. Yee JC, de Leon Gatti M, Philp RJ, Yap M, Hu WS (2008) Genomic and proteomic exploration of CHO and hybridoma cells under sodium butyrate treatment. Biotechnol Bioeng 99:1186-1204
64. Allen MJ, Boyce JP, Trentalange MT, Treiber DL, Rasmussen B, Tillotson B, Davis R, Reddy P (2008) Identi fi cation of novel small molecule enhancers of protein production by cultured mammalian cells. Biotechnol Bioeng 100:1193-1204
65. Hwang SO, Lee GM (2009) Effect of Akt overexpression on programmed cell death in antibody-producing Chinese hamster ovary cells. J Biotechnol 139:89-94
66. Chen J, Ghazawi FM, Bakkar W, Li Q (2006) Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B. Mol Cancer 5:71
67. Yun YR, Won JE, Jeon E, Lee S, Kang W, Jo H, Jang JH, Shin US, Kim HW (2010) Fibroblast growth factors: Biology, function, and application for tissue regeneration. J Tissue Eng 2010: 218142
68. Sheng Z, Liang Y, Lin CY, Comai L, Chirico WJ (2005) Direct regulation of rRNA transcription by fi broblast growth factor 2. Mol Cell Biol 25:9419-9426
69. Fox SR, Yap MX, Yap MG, Wang DI (2005) Active hypothermic growth: A novel means for increasing total interferon-gamma production by Chinese-hamster ovary cells. Biotechnol Appl Biochem 41:265-272
70. Wulhfard S, Tissot S, Bouchet S, Cevey J, De Jesus M, Hacker DL, Wurm FM (2008) Mild hypothermia improves transient gene expression yields several fold in Chinese hamster ovary cells. Biotechnol Prog 24:458-465
71. Han YK, Koo TY, Lee GM (2009) Enhanced interferon-beta production by CHO cells through elevated osmolality and reduced culture temperature. Biotechnol Prog 25:1440-1447
72. Pham PL, Perret S, Cass B, Carpentier E, St-Laurent G, Bisson L, Kamen A, Durocher Y (2005) Transient gene expression in HEK293 cells: Peptone addition posttransfection improves recombinant protein synthesis. Biotechnol Bioeng 90:332-344
73. Sun X, Goh PE, Wong KT, Mori T, Yap MG (2006) Enhancement of transient gene expression by fed-batch culture of HEK 293 EBNA1 cells in suspension. Biotechnol Lett 28:843-848
74. Sandberg H, Lutkemeyer D, Kuprin S, Wrangel M, Almstedt A, Persson P, Ek V, Mikaelsson M (2006) Mapping and partial characterization of proteases expressed by a CHO production cell line. Biotechnol Bioeng 95:961-971
75. Robert F, Bierau H, Rossi M, Agugiaro D, Soranzo T, Broly H, Mitchell-Logean C (2009) Degradation of an Fc-fusion recombinant protein by host cell proteases: Identi fi cation of a CHO cathepsin D protease. Biotechnol Bioeng 104:1132-1141
76. Andersen CR, Nielsen LS, Baer A, Tolstrup AB, Weilguny D (2011) Efficient expression from one CMV enhancer controlling two core promoters. Mol Biotechnol 48:128-137
77. Schlatter S, Stans fi eld SH, Dinnis DM, Racher AJ, Birch JR, James DC (2005) On the optimal ratio of heavy to light chain genes for Efficient recombinant antibody production by CHO cells. Biotechnol Prog 21:122-133
78. Bentley KJ, Gewert R, Harris WJ (1998) Differential ef fi ciency of expression of humanized antibodies in transient transfected mammalian cells. Hybridoma 17:559-567
79. Nettleship JE, Ren J, Rahman N, Berrow NS, Hatherley D, Barclay AN, Owens RJ (2008) A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells. Protein Expr Purif 62:83-89
80. Zhao Y, Gutshall L, Jiang H, Baker A, Beil E, Obmolova G, Carton J, Taudte S, Amegadzie B (2009) Two routes for production and puri fi cation of Fab fragments in biopharmaceutical discovery research: Papain digestion of mAb and transient expression in mammalian cells. Protein Expr Purif 67:182-189
81. Zhang J, Liu X, Bell A, To R, Baral TN, Azizi A, Li J, Cass B, Durocher Y (2009) Transient expression and puri fi cation of chimeric heavy chain antibodies. Protein Expr Purif 65:77-82
82. Haack A, Schmitt C, Poller W, Oldenburg J, Han fl and P, Brackmann HH, Schwaab R (1999) Analysis of expression kinetics and activity of a new B-domain truncated and fulllength FVIII protein in three different cell lines. Ann Hematol 78:111-116
83. Gaudry JP, Arod C, Sauvage C, Busso S, Dupraz P, Pankiewicz R, Antonsson B (2008) Puri fi cation of the extracellular domain of the membrane protein GlialCAM expressed in HEK and CHO cells and comparison of the glycosylation. Protein Expr Purif 58:94-102
84. Van den Nieuwenhof IM, Koistinen H, Easton RL, Koistinen R, Kamarainen M, Morris HR, Van Die I, Seppala M, Dell A, Van den Eijnden DH (2000) Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin-A can be produced in human kidney 293 cells but not in Chinese hamster ovary cells. Eur J Biochem 267:4753-4762
85. Suen KF, Turner MS, Gao F, Liu B, Althage A, Slavin A, Ou W, Zuo E, Eckart M, Ogawa T, Yamada M, Tuntland T, Harris JL, Trauger JW (2010) Transient expression of an IL-23R extracellular domain Fc fusion protein in CHO vs. HEK cells results in improved plasma exposure. Protein Expr Purif 71:96-102
86. Tchoudakova A, Hensel F, Murillo A, Eng B, Foley M, Smith L, Schoenen F, Hildebrand A, Kelter AR, Ilag LL, Vollmers HP, Brandlein S, McIninch J, Chon J, Lee G, Cacciuttolo M (2009) High level expression of functional human IgMs in human PER.C6 cells. MAbs 1:163-171
87. Jones D, Kroos N, Anema R, van Montfort B, Vooys A, van der Kraats S, van der Helm E, Smits S, Schouten J, Brouwer K, Lagerwerf F, van Berkel P, Opstelten DJ, Logtenberg T, Bout A (2003) High-level expression of recombinant IgG in the human cell line per.c6. Biotechnol Prog 19:163-168
88. Niklas J, Schrader E, Sandig V, Noll T, Heinzle E (2011) Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic fl ux analysis. Bioprocess Biosyst Eng 34: 533-545
89. Schiedner G, Hertel S, Bialek C, Kewes H, Waschutza G, Volpers C (2008) Efficient and reproducible generation of high-Expressing, stable human cell lines without need for antibiotic selection. BMC Biotechnol 8:13
90. Brown SW, Mehtali M (2010) The avian EB66(R) cell line, application to vaccines, and therapeutic protein production. PDA J Pharm Sci Technol 64:419-425
91. Kramer O, Klausing S, Noll T (2010) Methods in mammalian cell line engineering: from random mutagenesis to sequence-specific approaches. Appl Microbiol Biotechnol 88:425-436
92. Johnson KC, Jacob NM, Nissom PM, Hackl M, Lee LH, Yap M, Hu WS (2011) Conserved microRNAs in Chinese hamster ovary cell lines. Biotechnol Bioeng 108:475-480
93. Hackl M, Jakobi T, Blom J, Doppmeier D, Brinkrolf K, Szczepanowski R, Bernhart SH, Siederdissen CH, Bort JA, Wieser M, Kunert R, Jeffs S, Hofacker IL, Goesmann A, Puhler A, Borth N, Grillari J (2011) Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identi fi cation, annotation and pro fi ling of microRNAs as targets for cellular engineering. J Biotechnol 153:62-75
94. Barron N, Sanchez N, Kelly P, Clynes M (2011) MicroRNAs: Tiny targets for engineering CHO cell phenotypes? Biotechnol Lett 33:11-21